Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.72% |
| Sep 30, 2025 | 42.69% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | 33.56% |
| Dec 31, 2024 | 19.64% |
| Sep 30, 2024 | 37.34% |
| Jun 30, 2024 | 23.76% |
| Mar 31, 2024 | 22.86% |
| Dec 31, 2023 | 47.31% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 36.42% |
| Mar 31, 2023 | 28.07% |
| Dec 31, 2022 | 26.92% |
| Sep 30, 2022 | 72.64% |
| Mar 31, 2022 | 61.89% |
| Dec 31, 2021 | 1.28% |
| Sep 30, 2021 | -87.25% |
| Jun 30, 2021 | -14.00% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | -43.57% |